Gutowski Mateusz, Klimkiewicz Jakub, Rustecki Bartosz, Michałowski Andrzej, Skalec Tomasz, Lubas Arkadiusz
Department of Anesthesiology and Intensive Care, Military Institute of Medicine-National Research Institute, 04-141 Warsaw, Poland.
Department of Internal Diseases, Nephrology and Dialysis, Military Institute of Medicine-National Research Institute, 04-141 Warsaw, Poland.
J Clin Med. 2024 Dec 10;13(24):7520. doi: 10.3390/jcm13247520.
Severe COVID-19 is associated with a generalized inflammatory response leading to peripheral and organ perfusion disorders. : This study aimed to evaluate the usefulness of peripheral and organ perfusion assessments in the prediction of prognosis and mortality in patients with severe COVID-19. : In the first 48 h of hospitalization, peripheral perfusion (saturation, Finger Infrared Thermography-FIT; Capillary Refill Time-CRT), and the color Doppler renal cortex perfusion (RCP) were estimated in a group of 102 severe COVID-19 patients. : In total, 40 patients experienced deterioration and required intensification of oxygen treatment, and 24 finally died. In comparison with a stable course of the disease, patients with deterioration had initially higher WBC, CRP, AST, LDH, and CRT, but a lower oxygenation ratio and RCP. Deceased patients were older, had higher CRP, LDH, and CRT, but lower hemoglobin, oxygenation ratio, and RCP compared to survivors. In the multivariable regression analysis from perfusion parameters, only RCP and CRT were independently linked with deterioration (OR 0.002, < 0.001; OR 1.825, = 0.003, respectively) and death (OR 0.001, = 0.004; OR 1.910, = 0.003, respectively). : Initial assessment of peripheral and organ perfusion can be helpful in identifying hospitalized severe COVID-19 patients with a higher risk of deterioration and death. Capillary Refill Time and Renal Cortical Perfusion were prognostic markers of deterioration or death. On the other hand, Finger Infrared Thermography and saturation were not statistically significant in predicting patient outcome. An RCP cut-off value below 0.127 and 0.112 [cm/s] and a Capillary Refill Time longer than 3.25 and 4.25 [s] indicate the risk of deterioration or death, respectively.
重症新型冠状病毒肺炎(COVID-19)与全身性炎症反应相关,可导致外周和器官灌注障碍。本研究旨在评估外周和器官灌注评估对预测重症COVID-19患者预后和死亡率的作用。在住院的前48小时内,对102例重症COVID-19患者进行了外周灌注(饱和度、手指红外热成像-FIT;毛细血管再充盈时间-CRT)以及彩色多普勒肾皮质灌注(RCP)评估。共有40例患者病情恶化,需要加强氧疗,其中24例最终死亡。与病情稳定的患者相比,病情恶化的患者最初白细胞、C反应蛋白(CRP)、天门冬氨酸氨基转移酶(AST)、乳酸脱氢酶(LDH)和CRT较高,但氧合比和RCP较低。与幸存者相比,死亡患者年龄更大,CRP、LDH和CRT更高,但血红蛋白、氧合比和RCP更低。在灌注参数的多变量回归分析中,只有RCP和CRT分别与病情恶化(OR 0.002,P<0.001;OR 1.825,P = 0.003)和死亡(OR 0.001,P = 0.004;OR 1.910,P = 0.003)独立相关。对外周和器官灌注的初始评估有助于识别住院的重症COVID-19患者中病情恶化和死亡风险较高的患者。毛细血管再充盈时间和肾皮质灌注是病情恶化或死亡的预后标志物。另一方面,手指红外热成像和饱和度在预测患者预后方面无统计学意义。RCP截止值低于0.127和0.112[cm/s]以及毛细血管再充盈时间长于3.25和4.25[s]分别表明病情恶化或死亡的风险。